To evaluate the efficacy of NiKu plus as supplementation in type 2 diabetic patients
Phase 2
Completed
- Conditions
- Health Condition 1: E08-E13- Diabetes mellitusHealth Condition 2: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2018/09/015647
- Lead Sponsor
- Dr JRKs Research and Pharmaceuticals Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 24
Inclusion Criteria
1.Proper written informed consent obtained from the patient before any procedure is being performed.
2.Male or female Type 2 DM patients on oral hypoglycemic agents, in the age group of 18-45 years.
3.Patient should have not participated in any other clinical trial during the past 3 months.
Exclusion Criteria
1.Patient who are unable to consume solid and liquid orals.
2.Patients who are having complications of Diabetes mellitus and suffering from other co morbid conditions.
3.Patients who are unable to sign informed consent.
4.Patient unwilling or unable to comply with study procedure.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage Change in the blood sugar levels before and after interventionTimepoint: DAY 0 day 1 day 3 day 6 and Day 7
- Secondary Outcome Measures
Name Time Method monitoring of adverse drug reactionsTimepoint: DAY 0 day 1 day 3 day 6 and Day 7